Establishment Labs Holdings (ESTA) Non-Current Assets (2017 - 2026)
Establishment Labs Holdings (ESTA) recorded quarterly Non-Current Assets of $105.2 million in Q1 2026, down 1.88% quarter-over-quarter from $107.2 million in Q4 2025, and up 3.48% on a YoY basis from $101.7 million in Q1 2025.
Establishment Labs Holdings (ESTA) Non-Current Assets (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Non-Current Assets history runs 10 years deep, the most recent figure standing at $105.2 million for Q1 2026.
- In Q1 2026, Non-Current Assets rose 3.48% year-over-year to $105.2 million; the TTM figure through Mar 2026 stood at $412.2 million (up 2.0% YoY), while the FY2025 annual figure was $107.2 million, up 3.31% from the prior year.
- Non-Current Assets was $105.2 million for Q1 2026 at Establishment Labs Holdings, down from $107.2 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $107.2 million in Q4 2025 to a low of $31.5 million in Q1 2022.
- Historically, Non-Current Assets has averaged $83.6 million across 5 years, with a median of $98.1 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Non-Current Assets surged 132.91% in 2022, then declined 0.44% in 2025.
- A 5-year view of Non-Current Assets shows it stood at $61.2 million in 2022, then surged by 53.28% to $93.7 million in 2023, then increased by 10.73% to $103.8 million in 2024, then climbed by 3.31% to $107.2 million in 2025, then slipped by 1.88% to $105.2 million in 2026.
- The last three Non-Current Assets figures came in at $105.2 million (Q1 2026), $107.2 million (Q4 2025), and $99.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 67.41 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.47 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.30 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 8.34 Bn |
| 10 | Establishment Labs Holdings | 2.54 Bn | 2.47 Bn | 42.34 Mn | 105.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 105.21 Mn |
| Dec 31, 2025 | 107.23 Mn |
| Sep 30, 2025 | 99.30 Mn |
| Jun 30, 2025 | 100.50 Mn |
| Mar 31, 2025 | 101.67 Mn |
| Dec 31, 2024 | 103.79 Mn |
| Sep 30, 2024 | 99.73 Mn |
| Jun 30, 2024 | 98.96 Mn |
| Mar 31, 2024 | 98.14 Mn |
| Dec 31, 2023 | 93.74 Mn |
| Sep 30, 2023 | 83.81 Mn |
| Jun 30, 2023 | 76.28 Mn |
| Mar 31, 2023 | 67.32 Mn |
| Dec 31, 2022 | 61.16 Mn |
| Sep 30, 2022 | 49.49 Mn |
| Jun 30, 2022 | 43.46 Mn |
| Mar 31, 2022 | 31.54 Mn |
| Dec 31, 2021 | 26.26 Mn |
| Sep 30, 2021 | 23.65 Mn |
| Jun 30, 2021 | 23.94 Mn |